Stifel resumed coverage on Altria with a new price target
$MO
Medicinal Chemicals and Botanical Products
Health Care
Stifel resumed coverage of Altria with a rating of Buy and set a new price target of $52.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2025 | Buy → Hold | Deutsche Bank | |
| 1/16/2025 | $54.00 | Equal-Weight | Morgan Stanley |
| 12/6/2024 | $55.00 → $65.00 | Neutral → Buy | BofA Securities |
| 10/8/2024 | $44.50 → $48.00 | Neutral | Citigroup |
| 1/23/2024 | Sell | UBS | |
| 4/14/2023 | $52.00 | Buy | Stifel |
| 11/10/2022 | $38.00 | Neutral → Sell | UBS |
| 6/29/2022 | $53.00 → $36.00 | Equal Weight → Underweight | Barclays |
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
Altria Group, Inc. (Altria) (NYSE:MO) held our 2025 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria's Chief Executive Officer, addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on www.altria.com. Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 11 nominees for our Board of Directors (Board) named in our 2025 Proxy Statement; ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025; approved, on an advisory b
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast of its 2025 Annual Meeting of Shareholders ("2025 Annual Meeting" or "meeting") on Thursday, May 15, 2025 at 9:00 a.m. Eastern Time. The 2025 Annual Meeting will be held virtually via live webcast. During the meeting, shareholders as of the 2025 Annual Meeting record date (March 25, 2025) will be able to vote their shares electronically and will be able to submit questions during the meeting as time permits. Although shareholders will be able to vote their shares during the meeting, they are encouraged to do so before the meeting using one of the methods described in the 2025 Proxy Statement. If you are not a shareholder
Altria Group, Inc. (NYSE:MO) today reports our 2025 first-quarter business results and reaffirms our guidance for 2025 full-year adjusted diluted earnings per share (EPS). "Our highly profitable traditional tobacco businesses performed well in a challenging environment in the first quarter," said Billy Gifford, Altria's Chief Executive Officer. "The smokeable products segment delivered solid adjusted operating companies income growth behind the strength of Marlboro. In the oral tobacco products segment, on! maintained momentum in a competitive marketplace as Helix invested strategically behind the brand. And shareholders continued to benefit from strong cash returns through dividends and s